Poster # 1060 Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study

Presenter: Kyle Cuneo, MD

About the Presenter:
Kyle Cuneo is in his final year of residency in the Department of Radiation Oncology at Duke University Medical Center. His research interests include SRS, SBRT, experimental therapeutics, radiosensitizers, and functional imaging. He is presenting a prospective pilot study on the use of SRS and bevacizumab for recurrent glioma.
Contact the presenter at: kc91@notes.duke.edu

Abstract:


E-mail a friend about this poster:
Enter email address: